Prostate Cancer Screening: The Need For Problem-Solving that Puts Men's Interests First

European Urology

Volumn 56, Issue 1, 2009, Pages 34-37

  Holmberg, Lars ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; DIGITAL RECTAL EXAMINATION; EDITORIAL; FOLLOW UP; GROUPS BY AGE; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; RISK REDUCTION; TUMOR BIOPSY;

AGED; BIOPSY; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; UNNECESSARY PROCEDURES;

EID: 67349265757     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.04.026     Document Type: Editorial

References (12)

1. Schröder F.H., Hugosson J., Roobol M.J., et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360 (2009) 1320-1328
2. Andriole G.L., Grubb III R.L., Buys S.S., et al. Mortality results from a randomized prostate cancer screening trial. N Engl J Med 360 (2009) 1310-1319
3. Ciatto S., Zappa M., Villers A., Paez A., Otto S.J., and Auvinen A. Contamination by opportunistic screening in the European randomized study of prostate cancer screening. BJU Int 92 (2003) 97-100
4. Hakama M., and Auvinen A. Cancer screening. In: Heggenhougen K., and Quah S.R. (Eds). International Encyclopedia of Public Health (2008), Academic Press, San Diego, CA 464-480
5. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977-1984
6. Barry M.J. Screening for prostate cancer-the controversy that refuses to die. N Engl J Med 360 (2009) 1351-1354
7. Wilt T.J., Brawer M.K., Barry M.J., et al. The Prostate Cancer Intervention versus Observation Trial: VA/NCI/AHRQ cooperative studies program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer. Contemp Clin Trials 30 (2009) 81-87
8. Donovan J., Hamdy F., Neal D., et al. Prostate Testing for Cancer and Treatment (ProtecT) feasibility study. Health Technol Assess 7 (2003) 1-88
9. Klotz L. Active surveillance for prostate cancer: trials and tribulations. World J Urol 26 (2008) 437-442
10. Paul J.R., Freeman A.W., and Perkins J.E. What and who is an epidemiologist? Comments on an editorial published in the April 1942 issue of the journal. Am J Publ Health 32 (1942) 867-869
11. Savitz D.A. Interpreting Epidemiologic Evidence: Strategies for Study Design and Analysis (2003), Oxford University Press, New York, NY
12. Popper K. The Myth of the Framework: In Defence of Science and Rationality (1995), Routledge, Abingdon, Oxon, UK